3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

By afschroeder • June 12, 2025

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant B, O'Neill WW, Guerrero ME, Rodriguez E, Kodali S, Ailawadi G, Rihal CS. 3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States. JACC Cardiovasc Interv. 2025 Jun 9;18(11):1454-1466. doi: 10.1016/j.jcin.2025.03.017. PMID: 40500016.

Tags: bioprosthetic mitral degeneration, Cardiology/Epi, Cedars Sinai DoM, mitral valve reintervention, mitral valve-in-valve procedure, Publications, Society for Thoracic Surgeons, Transcatheter Valve Therapy Registry, transseptal approach

Related Posts

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic Stroke

Royan R, Ikeaba U, Alhanti B, Stamm B, Mac Grory B, Prabhakaran S, Maas MB, Fonarow GC, Messe SR, Mamer LE, Goldstein JN, Saver JL,[...]

Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity

Han X, Wen D, Fu R, Soto J, Song Y, Wu Y, Wang Z, Lin X, Yu J, Sheng T, Li S, Gu Z, He[...]

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

Eusuff S, Kim J, Fatima Z, Yalcinkaya D, Sahashi Y, Sandhu A, Nguyen LH, Ambrosy AP, Cheng PP, Chang ST, Go AS, Ahmad FS, Cheung[...]